Bactericidal kinetics of marine-derived napyradiomycins against contemporary methicillin-resistant Staphylococcus aureus

Marine Drugs

Volumn 9, Issue 4, 2011, Pages 680-689

  Haste, Nina M ^a,b   Farnaes, Lauge ^b,c   Perera, Varahenage R ^c   Fenical, William ^a,b   Nizet, Victor ^a,c   Hensler, Mary E ^c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Antibacterial; Antibiotic; Methicillin resistant staphylococcus aureus (MRSA); Napyradiomycin; Time kill

Indexed keywords

A 80915A; A 80915B; ANTIBIOTIC AGENT; GENTAMICIN; NAPYRADIOMYCIN DERIVATIVE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CELL STRAIN HCT116; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG STRUCTURE; HUMAN; HUMAN CELL; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STAPHYLOCOCCUS AUREUS; STREPTOMYCES; VANCOMYCIN RESISTANT ENTEROCOCCUS;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STREPTOMYCES SP.;

EID: 79955615962     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md9040680     Document Type: Article

References (27)

1. Como-Sabetti, K.; Harriman, K.H.; Buck, J.M.; Glennen, A.; Boxrud, D.J.; Lynfield, R. Community-associated methicillin-resistant Staphylococcus aureus: Trends in case and isolate characteristics from six years of prospective surveillance. Public Health Rep. 2009, 124, 427-435.
2. Boucher, H.W.; Talbot, G.H.; Bradley, J.S.; Edwards, J.E.; Gilbert, D.; Rice, L.B.; Scheld, M.; Spellberg, B.; Bartlett, J. Bad bugs, no drugs: No ESKAPE! An update from the infectious diseases society of America. Clin. Infect. Dis. 2009, 48, 1-12.
3. Spellberg, B.; Talbot, G.H.; Boucher, H.W.; Bradley, J.S.; Gilbert, D.; Scheld, W.M.; Edwards, J., Jr.; Bartlett, J.G. Antimicrobial agents for complicated skin and skin-structure infections: Justification of noninferiority margins in the absence of placebo-controlled trials. Clin. Infect. Dis. 2009, 49, 383-391.
4. Clardy, J.; Fischbach, M.A.; Walsh, C.T. New antibiotics from bacterial natural products. Nat. Biotechnol. 2006, 24, 1541-1550.
5. Hopwood, D.A. Therapeutic treasures from the deep. Nat. Chem. Biol. 2007, 3, 457-458.
6. Shiomi, K.; Iinuma, H.; Hamada, M.; Naganawa, H.; Manabe, M.; Matsuki, C.; Takeuchi, T.; Umezawa, H. Novel antibiotics napyradiomycins. Production, isolation, physico-chemical properties and biological activity. J. Antibiot. (Tokyo) 1986, 39, 487-493.
7. Shiomi, K.; Nakamura, H.; Iinuma, H.; Naganawa, H.; Isshiki, K.; Takeuchi, T.; Umezawa, H.; Iitaka, Y. Structures of new antibiotics napyradiomycins. J. Antibiot. (Tokyo) 1986, 39, 494-501.
8. Shiomi, K.; Iinuma, H.; Naganawa, H.; Isshiki, K.; Takeuchi, T.; Umezawa, H. Biosynthesis of napyradiomycins. J. Antibiot. (Tokyo) 1987, 40, 1740-1745.
9. Shiomi, K.; Nakamura, H.; Iinuma, H.; Naganawa, H.; Takeuchi, T.; Umezawa, H.; Iitaka, Y. New antibiotic napyradiomycins A2 and B4 and stereochemistry of napyradiomycins. J. Antibiot. (Tokyo) 1987, 40, 1213-1219.
10. Fukuda, D.S.; Mynderse, J.S.; Baker, P.J.; Berry, D.M.; Boeck, L.D.; Yao, R.C.; Mertz, F.P.; Nakatsukasa, W.M.; Mabe, J.; Ott, J.; et al. A80915, a new antibiotic complex produced by Streptomyces aculeolatus. Discovery, taxonomy, fermentation, isolation, characterization, and antibacterial evaluation. J. Antibiot. (Tokyo) 1990, 43, 623-633.
11. Fukuda, D.S.; Mynderse, J.S.; Yao, R.C. Antibiotic A80915 and process for its production. U.S. Patent 4,904,590, 27 February 1990.
12. Gomi, S.; Ohuchi, S.; Sasaki, T.; Itoh, J.; Sezaki, M. Studies on new antibiotics SF2415. II. The structural elucidation. J. Antibiot. (Tokyo) 1987, 40, 740-749.
13. Shomura, T.; Gomi, S.; Ito, M.; Yoshida, J.; Tanaka, E.; Amano, S.; Watabe, H.; Ohuchi, S.; Itoh, J.; Sezaki, M.; et al. Studies on new antibiotics SF2415. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities. J. Antibiot. (Tokyo) 1987, 40, 732-739.
14. Umezawa, K.; Masuoka, S.; Ohse, T.; Naganawa, H.; Kondo, S.; Ikeda, Y.; Kinoshita, N.; Hamada, M.; Sawa, T.; Takeuchi, T. Isolation from Streptomyces of a novel naphthoquinone compound, naphthablin, that inhibits Abl oncogene functions. J. Antibiot. (Tokyo) 1995, 48, 604-607.
15. Jensen, P.R.; Gontang, E.; Mafnas, C.; Mincer, T.J.; Fenical, W. Culturable marine actinomycete diversity from tropical Pacific Ocean sediments. Environ. Microbiol. 2005, 7, 1039-1048.
16. Cho, J.Y.; Kwon, H.C.; Williams, P.G.; Jensen, P.R.; Fenical, W. Azamerone, a terpenoid phthalazinone from a marine-derived bacterium related to the genus Streptomyces (Actinomycetales). Org. Lett. 2006, 8, 2471-2474.
17. Soria-Mercado, I.E.; Prieto-Davo, A.; Jensen, P.R.; Fenical, W. Antibiotic terpenoid chloro-dihydroquinones from a new marine actinomycete. J. Nat. Prod. 2005, 68, 904-910.
18. Soria-Mercado, I.E.; Jensen, P.R.; Fenical, W.; Kassel, S.; Golen, J. 3,4a-Dichloro-10a-(3-chloro-6-hydroxy-2,2,6-trimethylcyclohexylmethyl)-6, 8-dihydroxy-2,2,7-trimethyl-3,4,4a,10a-tetrahydro-2H-benzo[g]chromene-5, 10-dione. Acta Crystallogr. 2004, E60, o1627-o1629.
19. Gallagher, K.A.; Fenical, W.; Jensen, P.R. Hybrid isoprenoid secondary metabolite production in terrestrial and marine actinomycetes. Curr. Opin. Biotechnol. 2010, 21, 794-800.
20. Sakoulas, G.; Eliopoulos, G.M.; Moellering, R.C., Jr.; Wennersten, C.; Venkataraman, L.; Novick, R.P.; Gold, H.S. Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin. Antimicrob. Agents Chemother. 2002, 46, 1492-1502.
21. Farnaes, L.L.L. Novel Analogs and a Protein Target for the Napyradiomycins. Ph.D. Thesis, University of California, San Diego, CA, USA, 2009.
22. Motohashi, K.; Sue, M.; Furihata, K.; Ito, S.; Seto, H. Terpenoids produced by actinomycetes: Napyradiomycins from Streptomyces antimycoticus NT17. J. Nat. Prod. 2008, 71, 595-601.
23. Motohashi, K.; Irie, K.; Toda, T.; Matsuo, Y.; Kasai, H.; Sue, M.; Furihata, K.; Seto, H. Studies on terpenoids produced by actinomycetes. 5-dimethylallylindole-3-carboxylic Acid and A80915G-8″-acid produced by marine-derived Streptomyces sp. MS239. J. Antibiot. (Tokyo) 2008, 61, 75-80.
24. Winter, J.M.; Moffitt, M.C.; Zazopoulos, E.; McAlpine, J.B.; Dorrestein, P.C.; Moore, B.S. Molecular basis for chloronium-mediated meroterpene cyclization: Cloning, sequencing, and heterologous expression of the napyradiomycin biosynthetic gene cluster. J. Biol. Chem. 2007, 282, 16362-16368.
25. Snyder, S.A.; Tang, Z.Y.; Gupta, R. Enantioselective total synthesis of (-)-Napyradiomycin A1 via asymmetric chlorination of an isolated olefin. J. Am. Chem. Soc. 2009, 131, 5744-5745.
26. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 7th ed.; Approved Standard M7-A7; CLSI: Wayne, PA, USA, 2006; Volume 26, No. 2.
27. Haste, N.M.; Perera, V.R.; Maloney, K.N.; Tran, D.N.; Jensen, P.; Fenical, W.; Nizet, V.; Hensler, M.E. Activity of the streptogramin antibiotic etamycin against methicillin-resistant Staphylococcus aureus. J. Antibiot. (Tokyo) 2010, 63, 219-224.